RCP appoints Professor Volmar Weissig to scientific advisory board
This article was originally published in Scrip
Executive Summary
RCP Therapeutics, a US biopharmaceutical company specialising in the converging nanotechnology and regenerative medical markets, has appointedProfessor Volkmar Weissig to its scientific advisory board. Professor Weissig is associate professor of pharmacology at the department of pharmaceutical sciences, Midwestern University College of Pharmacy, Glendale, Arizona.